Back to search
Phase I clinical trial of MLN8054, a selective inhibitor of Aurora A kinase
Data up to Jan 2025
Published2007
Citations13
References0
Total Citations Per Year
Abstract
References (0)
No references found
Cited By (0)
No citing papers found in database